Nomura Holdings Inc Anavex Life Sciences Corp. Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 18, 2022
SELL
$9.74 - $17.69 $219,539 - $398,732
-22,540 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$16.88 - $23.31 $2.15 Million - $2.97 Million
-127,460 Reduced 84.97%
22,540 $391,000
Q3 2021

Nov 15, 2021
BUY
$16.82 - $25.75 $2.52 Million - $3.86 Million
150,000 New
150,000 $2.69 Million

Others Institutions Holding AVXL

# of Institutions
157
Shares Held
27.4M
Call Options Held
515K
Put Options Held
838K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $875M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email